Pharma Reaserch Prod Co Ltd (214450) — Free Cash Flow Generation Index
Pharma Reaserch Prod Co Ltd (214450) has a Free Cash Flow Generation Index of 0.87x as of December 2025. Free cash flow of ₩53.74 Billion represents 1% of operating cash flow (₩61.53 Billion). Read Pharma Reaserch Prod Co Ltd (214450) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pharma Reaserch Prod Co Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Pharma Reaserch Prod Co Ltd across 11 annual periods. Explore 214450 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for Pharma Reaserch Prod Co Ltd. For the full company profile including market capitalisation, see Pharma Reaserch Prod Co Ltd (214450) market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | ₩147.38 Billion | ₩183.16 Billion | ₩35.78 Billion | ▲ +13.2% |
| 2024 | 0.71x | ₩99.40 Billion | ₩139.88 Billion | ₩38.73 Billion | ▼ -10.8% |
| 2023 | 0.80x | ₩51.75 Billion | ₩64.95 Billion | ₩13.20 Billion | ▲ +13.7% |
| 2022 | 0.70x | ₩41.65 Billion | ₩59.40 Billion | ₩17.76 Billion | ▲ +10.3% |
| 2021 | 0.64x | ₩41.51 Billion | ₩65.30 Billion | ₩20.64 Billion | ▲ +788.4% |
| 2020 | -0.09x | ₩-2.99 Billion | ₩32.39 Billion | ₩34.78 Billion | ▼ -106.2% |
| 2019 | 1.50x | ₩28.86 Billion | ₩19.27 Billion | ₩9.59 Billion | ▼ -76.9% |
| 2018 | 6.50x | ₩33.80 Billion | ₩5.20 Billion | ₩28.60 Billion | ▲ +243.3% |
| 2017 | 1.89x | ₩16.19 Billion | ₩8.56 Billion | ₩7.63 Billion | ▲ +52.6% |
| 2016 | 1.24x | ₩10.12 Billion | ₩8.16 Billion | ₩1.96 Billion | ▲ +20.5% |
| 2015 | 1.03x | ₩16.49 Billion | ₩16.02 Billion | ₩462.99 Million | — |